View of Hsa-miR-662 as a New Prognostic Biomarker in Patients with Breast Cancer; In-silico and Experimental Study

Return to Article Details Hsa-miR-662 as a New Prognostic Biomarker in Patients with Breast Cancer; In-silico and Experimental Study Download Download PDF